AI-generated summary
The authors ran a randomized, double-blind trial of 82 patients with rheumatoid arthritis, comparing laser therapy at 785 nm with a placebo laser on hand pain and function. Most outcomes showed no significant difference between groups, and a few differences favored either group. The authors conclude that this laser was not effective at the wavelength, dose and power studied.
- Participants
- 82
- Who or what was studied
- Patients with rheumatoid arthritis affecting the hands
- Wavelengths
- 785 nm
- Limits stated in the abstract
- The abstract reports several statistically significant differences in both directions among many comparisons, which may reflect multiple testing, and it does not report the full details of the intervention or follow-up duration.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 785 nm
- Power
- 70 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Control group, Wavelength, Inflammation, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.